Award
National Institute of Allergy and Infectious Diseases 5R01AI174540-03
A role for pharmaceutical control of protease-activated receptor-2 for the treatment of asthma
Recipient
University of Arizona
Award Amount
$761,371.00
Ceiling
$761,371.00
Awarded
June 01, 2026
Identifier
5R01AI174540-03
NIH grant awarded to University of Arizona for research on pharmaceutical control of protease-activated receptor-2 to treat asthma, funded by NIAID.
Description
The project focuses on developing novel therapeutics targeting PAR2 for asthma. The project involves in vitro and in vivo studies, with a focus on pharmacological modulation of PAR2.